Introducing a new treatment
for adults with moderately to severely active rheumatoid arthritis (RA)
Olumiant, pronounced: [O-loo’-mē-ant]
Olumiant® (baricitinib) is an oral prescription medicine called a Janus kinase (JAK) inhibitor used to treat adults with moderate to severe rheumatoid arthritis (RA) who have not responded well enough to or could not tolerate at least one medicine called a tumor necrosis factor (TNF) antagonist. It is not known if Olumiant is safe and effective in children.
Olumiant Together™ is here to support you every step of the way.
Request a savings card today in a few short steps.
Government beneficiaries excluded, subject to terms and conditions.